Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> H >> 2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one

2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one
[CAS# 41276-02-2]

List of Suppliers
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Selleck Chemicals LLC USA Inquire  
+1 (713) 535-9129
info@selleckchem.com
Chemical manufacturer
chemBlink standard supplier since 2014
Amadis Chemical Co., Ltd. China Inquire  
+86 (571) 8992-5085
sales@amadischem.com
Chemical manufacturer since 2010
chemBlink standard supplier since 2015
Complete supplier list of 2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one
Identification
Classification Biochemical >> Inhibitor >> PI3K/Akt/mTOR inhibitor (PI3K/Akt/mTOR) >> Akt inhibitor
Name 2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one
Synonyms NSC 350625
Molecular Structure CAS # 41276-02-2, 2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one, NSC 350625
Molecular Formula C24H26N4O
Molecular Weight 386.49
CAS Registry Number 41276-02-2
Properties
Solubility Insoluble (5.8E-3 g/L) (25 ºC), Calc.*
Density 1.24±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
Safety Data
SDS Available
Market Analysis Reports
List of Reports Available for 2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one
Related Products
Hexahydro-1-methyl-3-(3-oxo-1-cyclohexen-1-yl)-2H-azepin-2-one  2,3,3a,4,6,7-Hexahydro-2-methyl-3-oxo-3a-(phenylmethyl)-5H-pyrazolo[4,3-c]pyridine-5-carboxylic acid 1,1-dimethylethyl ester  N-[(1S)-1-[[[(4R,7S)-Hexahydro-7-methyl-3-oxo-1-(2-pyridinylsulfonyl)-1H-azepin-4-yl]amino]carbonyl]-3-methylbutyl]-2-benzofurancarboxamide  1,2,5,6,7,8-Hexahydro-8-methyl-2-oxo-3-quinolinecarboxylic acid  1,2,5,6,7,8-Hexahydro-7-methyl-2-oxo-3-quinolinecarboxylic acid  2,4,6,7,8,9-Hexahydro-4-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one hydrochloride (1:2)  (5R)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine  (5S)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine  [(7R)-Hexahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone  [(7S)-Hexahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone  2,4,6,7,8,9-Hexahydro-4-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one  (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione  (±)-5,7,8,13,13b,14-Hexahydro-2-methoxybenz[g]indolo[2,3-a]quinolizine  Hexahydro-6-methoxy-2,7-diphenyl-m-dioxino[4',5':5,6]pyrano[3,4-d]oxazole-8(6H)-thione  Hexahydro-4-[(2-methoxyethyl)amino]-1H-azepine-1-carboxylic acid tert-butyl ester  (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid  [2R-(2alpha,4alpha,4abeta,5alpha,7beta,7abeta)]-Hexahydro-4-methoxy-7a-methyl-8-methylene-2,5-methanocyclopenta-1,3-dioxin-7-ol  2-[(3a,4a,5,8a,9,9a-Hexahydro-9-methoxy-7-methyl-5-oxo-4H-furo[3,2-g][1]benzopyran-4-yl)oxy]butanoic acid 2-(diethylamino)ethyl ester hydrochloride  1,3,4,6,7,11b-Hexahydro-10-methoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizine-2,9-diol  (2R,3R,11bR)-1,3,4,6,7,11b-Hexahydro-10-methoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizine-2,9-diol